MedTrace Logo

Assessment of Periodic Screening of Women With Denser Breast Using WBUS and DBT

NCT02643966 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6266

Last updated 2023-06-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the role of technologist-performed whole breast ultrasound for detecting breast cancer in the screening population of women with dense breasts.

Conditions

Interventions

DEVICE

Whole breast ultrasound

Breast cancer screening with whole breast ultrasound

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wendie Berg

    lead OTHER

Principal Investigators

  • Wendie Berg, MD, PhD · University of Pittsburgh

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02643966 on ClinicalTrials.gov